The Feasibility and Safety of Laparoscopic Splenectomy for Massive Splenomegaly: A Comparative Study

2011 ◽  
Vol 171 (1) ◽  
pp. e55-e60 ◽  
Author(s):  
Jin Zhou ◽  
Zhong Wu ◽  
Yunqiang Cai ◽  
Yichao Wang ◽  
Bing Peng
2003 ◽  
Vol 238 (2) ◽  
pp. 235-240 ◽  
Author(s):  
Ameet G. Patel ◽  
Jane E. Parker ◽  
Ben Wallwork ◽  
Keith B. Kau ◽  
Nora Donaldson ◽  
...  

2014 ◽  
Vol 151 (2) ◽  
pp. 153-154 ◽  
Author(s):  
H. Tranchart ◽  
P. Lainas ◽  
D. Tzanis ◽  
S. Ferretti ◽  
G. Pourcher ◽  
...  

2010 ◽  
Vol 24 (8) ◽  
pp. 2008-2012 ◽  
Author(s):  
Artan Reso ◽  
Mantaj Singh Brar ◽  
Neal Church ◽  
Philip Mitchell ◽  
Elijah Dixon ◽  
...  

2006 ◽  
Vol 38 (3) ◽  
pp. 176-182 ◽  
Author(s):  
E. M. Targarona ◽  
C. Balagué ◽  
R. Berindoague ◽  
C. Martinez ◽  
P. Hernandez ◽  
...  

2019 ◽  
Vol 69 (3) ◽  
pp. 215-220
Author(s):  
Makoto Kurabayashi ◽  
Daisuke Yoshinari ◽  
Kengo Takahashi ◽  
Mitsunobu Kobayashi ◽  
Fujio Makita ◽  
...  

2018 ◽  
Vol 84 (6) ◽  
pp. 1033-1038 ◽  
Author(s):  
Guangjin Tian ◽  
Deyu Li ◽  
Haibo Yu ◽  
Yadong Dong ◽  
Huanzhou Xue

This study was performed to evaluate the feasibility of the splenic bed laparoscopic splenectomy approach (SBLS) for massive splenomegaly (≥30 cm) in patients with hypersplenism secondary to portal hypertension and liver cirrhosis. Patients who underwent laparoscopic splenectomy (LS) from January 2012 to December 2016 were retrospectively reviewed. We performed LS in 83 patients with massive splenomegaly (≥30 cm) secondary to portal hypertension and liver cirrhosis. Of these patients, 37 underwent the SBLS and 46 underwent anterior LS (ALS). Five patients in the ALS group and none in the SBLS group underwent conversion to open surgery. The operation time, intraoperative blood loss volume, transfusion volume, frequency of transfusion, hemorrhage of short gastric vessels, conversion rate, postoperative hospital stay, and incidence of pancreatic fistula were all significantly lower in the SBLS than ALS group (all P < 0.05). No death or postoperative bleeding occurred in the two groups, and there were no significant differences in age, gender, spleen size, hemoglobin level, platelet count, prothrombin time, Child-Pugh class, hypoproteinemia, or ascites (all P > 0.05). The SBLS is more feasible and effective than ALS in patients with massive splenomegaly (≥30 cm) secondary to portal hypertension and liver cirrhosis.


2021 ◽  
Vol 89 (9) ◽  
pp. 1555-1567
Author(s):  
HISHAM OMRAN, M.D.; MAHMOUD A. EL-SHAFEI, M.D. ◽  
MARK M. LABIB, M.Sc.; HOSSAM S. ABD EL-RAHIM, M.D.

Sign in / Sign up

Export Citation Format

Share Document